Episode 1580 • • 44:23 - 47:57
1580: Coup Map
Wegovy Heart Benefits, Dr. Jen Ashton and Obesity Medicine
Dr. Jen Ashton reported on preliminary data suggesting that the weight loss drug Wegovy may reduce the risk of heart attacks and strokes by 20%. The drug maker plans to seek FDA approval for cardiovascular indications, which could expand insurance coverage. The segment also examines the credentials of the American Board of Obesity Medicine and the societal stigma surrounding medical weight loss interventions.